Clinical Trials Logo

Clinical Trial Summary

It is planned to compare the efficacy and safety of cefdinir and cefdinir/clavulanic acide treatments in acute exacerbation of chronic bronchitis (AECB) and community-acquired pneumoniae (CAP) patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03400735
Study type Interventional
Source Neutec Ar-Ge San ve Tic A.S
Contact Neutec R&D
Phone 00902128505102
Email iremkaraman@neutecrdc.com
Status Recruiting
Phase Phase 4
Start date November 1, 2017
Completion date August 1, 2018

See also
  Status Clinical Trial Phase
Completed NCT01979926 - Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis Phase 2
Recruiting NCT03132610 - A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis Phase 4